abagovomab 19
abciximab 21
abituzumab 19
abrilumab 18
actoxumab 10
adalimumab 17
aducanumab 8
afasevikumab 14
alacizumab_pegol 11
alemtuzumab 20
alirocumab 15
amatuximab 29
andecaliximab 17
anifrolumab 17
anrukinzumab 16
aprutumab 10
aprutumab_ixadotin 10
arcitumomab 14
ascrinvacumab 4
atezolizumab 15
atinumab 14
avelumab 11
basiliximab 18
bavituximab 25
begelomab 16
benralizumab 20
bevacizumab_beta 18
bezlotoxumab 10
bimagrumab 10
bleselumab 12
blinatumomab 24
blosozumab 26
bococizumab 15
brazikumab 14
brentuximab_vedotin 24
briakinumab 15
brodalumab 6
brolucizumab 22
brontictuzumab 20
burosumab 17
cabiralizumab 23
camrelizumab 10
canakinumab 20
cantuzumab_ravtansin 35
carlumab 12
carotuximab 23
cergutuzumab_amunaleukin2 22
cergutuzumab_amunaleukin 22
certolizumab_pegol 24
cetiximab 37
citatuzumab_bogatox 24
cixutumumab 17
clivatuzumab_tetraxetan 14
codrituzumab 28
conatumumab 9
concizumab 27
crenezumab 18
crizanlizumab 23
crotedumab 19
dacetuzumab 21
daclizumab 10
dalotuzumab 28
dapirolizumab_pegol 22
daratumumab 13
dectrekumab 8
demcizumab 19
denosumab 8
depatuxizumab 17
depatuxizumab_mafodotin 17
dezamizumab 13
dinutuximab 29
diridavumab 11
domagrozumab 13
drozitumab 9
duligotuzumab 17
durvalumab 4
dusigitumab 7
efalizumab 27
efungumab 23
eldelumab 13
elezanumab 16
elgemtumab 11
elotuzumab 10
emactuzumab 14
emapalumab 25
emibetuzumab 14
enavatuzumab 23
enfortumab_vedotin 11
enoblituzumab 14
enokizumab 21
enoticumab 15
ensituximab 22
eptinezumab 14
erenumab 14
etaracizumab 15
etrolizumab 22
evinacumab 20
evolocumab 10
farletuzumab 3
fasinumab 16
fezakinumab 12
fibatuzumab 6
ficlatuzumab 17
firivumab 27
flanvotumab 12
fletikumab 14
foralumab 9
foravirumab 12
fremanezumab 26
fresolimumab 16
fulranumab 18
futuximab 17
galcanezumab 15
ganitumab 19
gantenerumab 10
gemetuzumab 20
gemtuzumab2 24
gemtuzumab 19
gevokizumab 20
girentuximab 27
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 17
ibalizumab 21
ibritumomab 22
icrucumab 7
idarucizumab 26
ifabotuzumab 6
imalumab 16
imgatuzumab 16
inclacumab 17
indatuximab_ravtansin 21
indusatumab 11
inebilizumab 22
intetumumab 10
iodine_girentuximab 27
ipilimumab 3
iratumumab 6
isatuximab 25
itolizumab 19
ixekizumab 29
labetuzumab_govitecan 15
lambrolizumab 20
lampalizumab 19
lanadelumab 17
landogrozumab 15
laprituximab 20
lebrikizumab 31
lendalizumab 22
lenzilumab 12
lifastuzumab_vedotin 24
ligelizumab 20
lilotomab 29
lirilumab 21
lodelcizumab 16
lokivetmab 22
lorvotuzumab_mertansin 19
lucatumumab 27
lumretuzumab 12
lupartumab 10
lutikizumab 18
margetuximab 27
milatuzumab 33
mirvetuximab 21
mirvetuximab_soravtansin 21
modotuximab 28
mogamulizumab 28
monalizumab 16
motavizumab 25
moxetumomab_pasudotox 22
namilumab 13
naratuximab 22
naratuximab_emtansin 22
narnatumab 14
navicixizumab2 22
navicixizumab 21
navivumab 29
necitumumab 9
nemolizumab 21
nesvacumab 13
nivolumab 11
obiltoxaximab 18
obinutuzumab 29
ocaratuzumab 18
ofatumumab 18
olaratumab 18
olokizumab 23
omalizumab 19
onartuzumab 19
ontuxizumab 21
opicinumab 13
orticumab 12
otelixizumab 32
oxelumab 11
ozanezumab 26
pamrevlumab 10
panobacumab 19
parsatuzumab 24
pasotuxizumab 19
pateclizumab 14
patritumab 14
pembrolizumab 20
perakizumab 21
pidilizumab 13
pinatuzumab_vedotin 16
plozalizumab 24
pogalizumab 20
polatuzumab_vedotin 20
ponezumab 30
prezalumab 11
pritoxaximab 20
quilizumab 19
racotumomab 24
radretumab 13
ralpancizumab 20
ramucirumab 13
ranevetmab 24
ranibizumab 18
refanezumab 20
remtolumab 16
rilotumumab 12
rinucumab 14
risankizumab 29
rituximab 16
rivabazumab 13
robatumumab 20
roledumab 20
romosozumab 17
rontalizumab 19
rosmantuzumab 19
rozanolixizumab 20
sacituzumab 19
sacituzumab_govitecan 19
samalizumab 22
sapelizumab 22
sarilumab 15
secukinumab 9
seribantumab 16
setoxaximab 35
sifalimumab 5
siltuximab 17
simtuzumab 23
sirukumab 9
solanezumab 25
solitomab 18
stamulumab 15
suptavumab 19
suvizumab 15
tabalumab 9
tadocizumab 11
tamtuvetmab 28
tanezumab 19
tarextumab 10
tavolixizumab 12
telisotuzumab 23
teplizumab 15
tesidolumab 16
tezepelumab 22
tigatuzumab 15
tildrakizumab 18
timolumab 12
tisotumab 8
tosatoxumab 25
tositumomab 22
tralokinumab 21
trastuzumab 21
tregalizumab 21
trevogrumab 11
ublituximab 25
urelumab 14
ustekinumab 22
utomilumab 23
vadastuximab 17
vadastuximab_talirin 17
vandortuzumab_vedotin 14
vantictumab 18
vanucizumab2 18
vanucizumab 25
varlilumab 12
vatelizumab 17
vedolizumab 18
veltuzumab 10
vesencumab 10
vorsetuzumab 17
vorsetuzumab_mafodotin 17
vunakizumab 26
xentuzumab 14
zatuximab 28
